PSWE-10 - Innovative therapies – what drugs will we see in 2030?
Chair(s)
Dr Rebecka Isaksson, FIP Scientific Secretary, United KingdomIntroduction
The past decade has been packed with proposals of innovative new approaches to target and treat disease. We are now starting to see these innovations reach the later stages of clinical trials and some are already on the market impacting and improving patients’ lives. This session will start with an introduction focusing on the drugs we are just now seeing on the market, and the ones we will hopefully see in the near future. In the main talks of the session, we will focus on how we can use fools such as CAR-T cells and nucleic acid drugs, that modify and modulate the body’s own cells and immune response to exert their effect.
Programme
| 13:30 – 14:00 |
Welcome and introduction – Snapshot of current innovative advances in drug development |
| 14:00 – 14:25 |
The future of CAR-T cells and their global applicability |
| 14:25 – 14:50 | Trends in nucleic acid drug development – mRNA and beyond Speaker to be confirmed |
| 14:50 – 15:00 | Q&A and closing by the chair |
Learning objectives
- To describe the new and emerging innovative techniques and therapies in drug development.
- To understand how nucleic acid drugs can revolutionize disease treatment.
- To understand the CAR-T research efforts in the African region.
Summary
- New innovative strategies in drug discovery and development are allowing us to treat new diseases and offer hope of new cures.
- Innovative therapies being developed in the African region.